Skip to content

Clinical trials

Hyperlipidemias trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: Japan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20051
20061
20071
20101
20133
20141
20163
20201
20211
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda4
Amgen3
Novartis Pharmaceuticals3
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan3
Eli Lilly and Company1
Kumamoto University1
Kyoto Prefectural University of Medicine1
Ministry of Health, Labour and Welfare, Japan1
Nagoya University1
Osaka Metropolitan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias21
Hypercholesterolemia8
Dyslipidemias7
Atherosclerosis5
Cardiovascular Diseases4
Diabetes Mellitus4
Hypertension4
Brain Ischemia3
Ischemic Stroke3
Recurrence3

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.